Pharmaceutical

First Physiomesh Lawsuit Goes to Trial in 2018

physiomesh First Physiomesh Lawsuit Goes to Trial in 2018The first lawsuit filed against Johnson & Johnson and subsidiary Ethicon Inc. over complaints the companies’ Physiomesh device failed is scheduled to go to trial in 2018, according to the Daily Hornet.

In June of 2016, Ethicon Inc. issued a market withdrawal at a global level for Physiomesh Flexible Composite Mesh due to the high rate of revision surgery required.

“Analysis of unpublished data from two large independent overseas hernia registries (Germany and Denmark) has shown that laparoscopic ventral hernia repair using Ethicon Physiomesh Flexible Composite Mesh has a higher rate of recurrence/reoperation compared to the average rates of other similar products among patients…” the hazard alert states.

Physiomesh is a medical device implanted via laparoscopic surgery to repair hernias. The device is designed to reinforce the abdominal wall to promote healing. However, the device has now been linked to a number of serious injuries, complications, and deaths.

In May of last year, Ethicon issued an urgent Field Safety Notice warning that the device seemed to have a high rate of re-opening.

Matthew Huff was the first to file a lawsuit on April 1, 2016, over complications from his Physiomesh, implanted in 2013 to help repair a ventral hernia.

Huff was overcome with severe abdominal pain, fever, nausea, chills, and redness in July 2015. Doctors diagnosed him with an infection, two abscesses and an intestinal fistula. He was treated appropriately, but is now left with serious health problems associated with the failed hernia mesh including two open abdominal wounds that require cleaning and dressing every day.

Huff’s lawsuit is set for trial on Jan. 22, 2018.